Ibritumomab and Tacrolimus Extended-Release Capsules
Determining the interaction of Ibritumomab and Tacrolimus Extended-Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab Tiuxetan
Generic Name: tacrolimus
Brand name: Astagraf XL, Envarsus XR, Prograf, Hecoria
Synonyms: Tacrolimus (oral and injection), Tacrolimus (Systemic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab-Tacrolimus Extended-Release Tablets
- Ibritumomab-Tacrolimus Granules for Suspension
- Ibritumomab-Tacrolimus Injection
- Ibritumomab-Tacrolimus Intravenous
- Ibritumomab-Tacrolimus oral and injection
- Ibritumomab-Tacrolimus Oral, Intravenous
- Tacrolimus Extended-Release Capsules-Ibritumomab Intravenous
- Tacrolimus Extended-Release Capsules-Ibritumomab Tiuxetan
- Tacrolimus Extended-Release Capsules-Ibrutinib
- Tacrolimus Extended-Release Capsules-Ibrutinib Capsules
- Tacrolimus Extended-Release Capsules-Ibrutinib Tablets
- Tacrolimus Extended-Release Capsules-Ibu